FDA Approved Medical Products for:

Cardiomyopathy due to anthracyclines

The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products.

Generic Name Dexrazoxane
Trade Name
(Manufacturer Name)
Zinecard (injection)
The FDA has approved this product to be used in this manner.
Cardiomyopathy associated with doxorubicin administration in women with metastatic breast cancer who have received a cumulative dose of 300mg/m2.
More Information about this product Drug Information Portal
Medline Plus Health Information